Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

C16 Biosciences

Explore full profile

C16 uses microbiology to brew sustainable, conflict-free palm oil to reduce global CO2 emissions

New York City, United StatesFounded 2018Food
Valuation $100–250M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for C16 Biosciences and the history behind them.

About C16 Biosciences

C16 Biosciences is a pioneering startup focused on creating sustainable, high-performance ingredients for consumer goods. The company operates in the biotechnology sector, specifically targeting the beauty, personal care, home care, and food product markets. By leveraging a proprietary biomanufacturing platform, C16 Biosciences produces ingredients that are not only better performing but also environmentally friendly. This approach addresses the current industry's challenges, such as supply and price volatility and increasing consumer and regulatory demands for sustainable products.

The company's primary clients are leading consumer goods manufacturers who seek to incorporate high-quality, sustainable ingredients into their products. These clients benefit from C16 Biosciences' innovative solutions, which help them meet the growing consumer demand for products that are both effective and eco-friendly.

C16 Biosciences operates on a B2B (business-to-business) model. It generates revenue by selling its biodesigned ingredients to consumer goods manufacturers. These manufacturers then use the ingredients in their products, which are sold to end consumers. By focusing on high-value, high-impact ingredients, C16 Biosciences positions itself as a crucial supplier in the supply chain of major consumer goods companies.

In summary, C16 Biosciences is at the forefront of the movement to decarbonize consumer products. By providing sustainable, high-performance ingredients, the company not only supports the health of the planet but also meets the evolving needs of its clients in the consumer goods industry.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
New York City, United States
Employees
27
Open positions
None listed
Dealroom signal
62.6/100
Sub-industry
Innovative Food
Sector
Food, Biotechnology, Microbiology, Synthetic Biology, Vegan, Sustainable Development Goals, Palm, Fermentation, Climate Tech, Hard Tech, Alternative Fats and Oils, YC S18
Business model
Manufacturing
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jan 2024 $1M $100M Elemental Excelerator ↗
GRANT✓Other financing Jan 2024 $3.5M — Bill & Melinda Gates Foundation ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

C16 Biosciences website traffic

Latest recorded traffic for C16 Biosciences is 460 monthly website visits, down 88.5% over the last three months. C16 Biosciences's team declined 12.9% over the past year.

Latest monthly visits460 3-month web change-88.5% 1-year team growth-12.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

24 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A2 investors entered at this stage

  • Breakthrough Energy Ventures
  • Elemental Excelerator

Other known investors18 additional known investors

  • Ali Tamaseb
  • Blu1877
  • Climate Capital
  • DCVC
  • Dorm Room Fund
  • Duro
  • E12 Ventures
  • Elemental Impact
  • For Good Ventures
  • Investo
  • Liquid 2 Ventures
  • Meach Cove Capital
  • New York Ventures
  • Pioneer Fund
  • Sinai Ventures
  • Soma Capital
  • Unreasonable Group
  • Zachary Bogue
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about C16 Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See C16 Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.